Company Encyclopedia
View More
name
VTR
300381.SZ
Guangdong VTR Bio-Tech Co., Ltd. researches, develops, produces, sells, and services biological enzyme preparations, biosynthetics, and nutrition and health products in China. The company offers feed, energy, washing, food, papermaking, and textile enzymes, as well as biotechnology solutions. It also provides active natural products.
1.585 T
300381.SZMarket value -Rank by Market Cap -/-

Financial Score

07/12/2025 Update
C
BiotechnologyIndustry
Industry Ranking55/81
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE0.25%D
    • Profit Margin0.78%C
    • Gross Margin47.86%B
  • Growth ScoreC
    • Revenue YoY3.46%C
    • Net Profit YoY-66.94%D
    • Total Assets YoY-2.14%D
    • Net Assets YoY-1.34%D
  • Cash ScoreB
    • Cash Flow Margin12787.53%A
    • OCF YoY3.46%C
  • Operating ScoreD
    • Turnover0.28D
  • Debt ScoreA
    • Gearing Ratio8.95%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    VTR released its performance for the first three quarters, with a net profit attributable to the parent company of 18.2044 million yuan, a decrease of 57.47%

    VTR released its Q3 2025 report, with operating revenue for the first three quarters amounting to 613 million yuan, a year-on-year increase of 0.77%. The net profit attributable to the parent company was 18.2044 million yuan, a year-on-year decrease of 57.47%. The net profit after deducting non-recurring gains and losses was 18.7673 million yuan, a year-on-year increase of 33.65%. The basic earnings per share were 0.0371 yuan

    Zhitong·
    SZ
    300381
    +0.29%
    Zhitong·
    SZ
    300381
    +0.29%

    VTR: The company has currently stopped the production of Vitamin B12

    VTR announced on September 19th that due to market reasons, the company has ceased production of Vitamin B12. At the same time, the company has conducted multiple pharmaceutical research and trials on plant extracts for animal use and obtained new product certificates. In terms of plant extracts for human use, various new products have been developed, and the extraction process has been optimized, continuously expanding overseas markets, especially in Europe and Southeast Asia. The preparation work for the German subsidiary has been completed, aiming for a sales breakthrough

    Zhitong·
    SZ
    300381
    +0.29%
    Zhitong·
    SZ
    300381
    +0.29%

    HAID GROUP, VTR and other newly established biotechnology companies

    According to the Qichacha APP, recently, Guangdong Haituo Biotechnology Co., Ltd. was established with a registered capital of 35 million yuan. The business scope includes: environmental protection monitoring; production, sales, processing, transportation, storage of agricultural products, and other related services. Qichacha's equity penetration shows that the company is jointly held by HAID GROUP, VTR, and others

    Zhitong·
    SZ
    002311
    -1.31%
    SZ
    300381
    +0.29%
    Zhitong·
    SZ
    002311
    -1.31%
    SZ
    300381
    +0.29%

    VTR: Net profit of 13.997 million yuan in the first half of 2025, a year-on-year decrease of 66.50%

    VTR announced that in the first half of 2025, operating revenue was 415 million yuan, a year-on-year increase of 4.48%. Net profit was 13.997 million yuan, a year-on-year decrease of 66.50%. The company plans not to distribute cash dividends, not to issue bonus shares, and not to convert reserves into share capital

    Zhitong·
    SZ
    300381
    +0.29%
    Zhitong·
    SZ
    300381
    +0.29%

    VTR released its first-quarter results, with a net profit attributable to the parent company of 4.8705 million yuan, a year-on-year decrease of 75.19%

    VTR released its Q1 2025 earnings report, with operating revenue of 202 million yuan, a year-on-year increase of 1.79%. However, the net profit attributable to the parent company was 4.8705 million yuan, a year-on-year decrease of 75.19%; the net profit after deducting non-recurring gains and losses was 8.6241 million yuan, a year-on-year decrease of 39.31%. The basic earnings per share were 0.0099 yuan/share

    Zhitong·
    SZ
    300381
    +0.29%
    Zhitong·
    SZ
    300381
    +0.29%
    © 2025 Longbridge｜Disclaimer